Cefapirina [INN-Spanish] en es it fr

Cefapirina [INN-Spanish] Brand names, Cefapirina [INN-Spanish] Analogs

Cefapirina [INN-Spanish] Brand Names Mixture

  • Isotamine B 300 (Isoniazid + Pyridoxine Hydrochloride)
  • Rifater (Isoniazid + Pyrazinamide + Rifampin)

Cefapirina [INN-Spanish] Chemical_Formula


Cefapirina [INN-Spanish] RX_link

No information avaliable

Cefapirina [INN-Spanish] fda sheet

Cefapirina [INN-Spanish] msds (material safety sheet)

Cefapirina_[INN-Spanish] MSDS

Cefapirina [INN-Spanish] Synthesis Reference

No information avaliable

Cefapirina [INN-Spanish] Molecular Weight

423.466 g/mol

Cefapirina [INN-Spanish] Melting Point

No information avaliable

Cefapirina [INN-Spanish] H2O Solubility

1030 mg/L

Cefapirina [INN-Spanish] State


Cefapirina [INN-Spanish] LogP


Cefapirina [INN-Spanish] Dosage Forms

Gel; Suspension

Cefapirina [INN-Spanish] Indication

For treatment of infections caused by susceptible bacteria.

Cefapirina [INN-Spanish] Pharmacology

Cephapirin is a first-generation cephalosporin that has a wide spectrum of activity against gram-positive and gram-negative organisms. Cephapirin is more resistant to beta-lactamases than are the penicillins and so is effective against staphylococci, with the exception of methicillin-resistant staphylococci.

Cefapirina [INN-Spanish] Absorption

No information avaliable

Cefapirina [INN-Spanish] side effects and Toxicity

Rats exposed via the oral route to cephapirin displayed low acute toxicity (LD50 = 14000 mg/kg). The most common adverse reactions are hypersensitivity reactions and alterations to liver function. Evidence of white blood cell disorders and anaemia were noted in some subjects.

Cefapirina [INN-Spanish] Patient Information

No information avaliable

Cefapirina [INN-Spanish] Organisms Affected

Enteric bacteria and other eubacteria